Literature DB >> 10857749

Comparative sequence analysis of the VHL tumor suppressor gene.

E R Woodward1, A Buchberger, S C Clifford, L D Hurst, N A Affara, E R Maher.   

Abstract

Comparative genome analysis may provide novel insights into gene evolution and function. To investigate the von Hippel-Lindau (VHL) disease tumor suppressor gene, we sequenced the VHL gene in seven primate species. Comparative analysis was performed for human, primate, and rodent VHL genes and for a putative Caenorhabditis elegans VHL homologue identified by database analysis. The VHL gene has two translation initiation sites (at codons 1 and 54); however, the relative importance of the full-length translation product (pVHL30) and that translated from the second internal translation initiation site (pVHL19) is unclear. The N-terminal sequence of pVHL30 contains eight copies of a GXEEX acidic repeat motif in human and higher primates, but only three copies were present in the marmoset, and only one copy was present in rodent VHL genes. Evolutionary analysis suggested that the N-terminal repetitive sequence in pVHL30 was of less functional importance than those regions present in both pVHL30 and pVHL19. The VHL gene product is reported to form complexes with various proteins including elongin B, elongin C, VBP-1, fibronectin, Spl, CUL2, and HIF-1. Although most of the regions in pVHL that had been implicated in binding specific proteins demonstrated evolutionary conservation, the carboxy-terminal putative VBP-1 binding site was less well conserved, suggesting that VBP-1 binding may have less functional significance. Although an amino acid substitution (K171T) close to the pVHL elongin binding region was found in baboon, analysis of the structure of human pVHL suggested that this substitution would not interfere with pVHL/elongin C interaction. In general, there was a good correlation between the pVHL domains that demonstrated most evolutionary conservation and those that were most frequently mutated in tumors. Analysis of human/C. elegans conservation and human germline and somatic mutation patterns identified a highly conserved mutation cluster region between codons 74 and 90. However, this region is likely to be important for the structural integrity of pVHL rather than representing an additional protein binding domain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857749     DOI: 10.1006/geno.2000.6144

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

1.  The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia.

Authors:  H Jiang; R Guo; J A Powell-Coffman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

2.  An 11-bp duplication in the promoter region of the VHL gene in a patient with cerebellar hemangioblastoma and renal oncocytoma.

Authors:  Lucia Anna Muscarella; Raffaela Barbano; Bartolomeo Augello; Vincenza Formica; Lucia Micale; Leopoldo Zelante; Leonardo D'Agruma; Giuseppe Merla
Journal:  J Hum Genet       Date:  2007-04-17       Impact factor: 3.172

Review 3.  von Hippel-Lindau disease: a clinical and scientific review.

Authors:  Eamonn R Maher; Hartmut Ph Neumann; Stéphane Richard
Journal:  Eur J Hum Genet       Date:  2011-03-09       Impact factor: 4.246

Review 4.  Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms.

Authors:  T Hsu
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

Review 5.  Surgical approaches in hereditary endocrine tumors.

Authors:  Maurizio Iacobone; Marilisa Citton; Giovanni Viel; Donatella Schiavone; Francesca Torresan
Journal:  Updates Surg       Date:  2017-04-28

6.  A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?

Authors:  Fatemeh Azimi; Ali Aghajani; Golnaz Khakpour; Samira Chaibakhsh
Journal:  Mol Genet Genomics       Date:  2022-08-25       Impact factor: 2.980

7.  Spinal cord hemangioblastoma : diagnosis and clinical outcome after surgical treatment.

Authors:  Joon Ho Na; Hyeong Soo Kim; Whan Eoh; Jong Hyun Kim; Jong Soo Kim; Eun-Sang Kim
Journal:  J Korean Neurosurg Soc       Date:  2007-12-20

Review 8.  Von Hippel-Lindau disease.

Authors:  Prashant Chittiboina; Russell R Lonser
Journal:  Handb Clin Neurol       Date:  2015

9.  Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma.

Authors:  Claire Taylor; Rachel A Craven; Patricia Harnden; Peter J Selby; Rosamonde E Banks
Journal:  Int J Oncol       Date:  2012-07-20       Impact factor: 5.650

10.  Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein.

Authors:  Giovanni Minervini; Gabriella M Mazzotta; Alessandro Masiero; Elena Sartori; Samantha Corrà; Emilio Potenza; Rodolfo Costa; Silvio C E Tosatto
Journal:  Sci Rep       Date:  2015-07-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.